Related Experiment Videos
Hemodynamics of the male fat distribution pattern
1Department of Clinical Physiology, Ostra Hospital, University of Göteborg, Sweden.
Blood Pressure. Supplement
|January 1, 1992
Summary
Central obesity, characterized by abdominal fat, is linked to higher blood pressure and insulin resistance. This study reveals a specific hemodynamic profile and altered stress responses in individuals with central obesity, potentially related to insulin metabolism.
Area of Science:
- Cardiovascular Physiology
- Metabolic Syndrome
Background:
- Abdominal obesity is a risk factor for hypertension and cardiovascular disease, often associated with metabolic issues like insulin resistance.
- Peripheral vascular changes are implicated in the development of hypertension and metabolic disturbances.
Purpose of the Study:
- To investigate the hemodynamic characteristics associated with abdominal obesity.
- To examine the circulatory responses to mental stress and hyperinsulinemia in relation to central fat distribution.
Main Methods:
- Assessed hemodynamic profiles (total peripheral resistance, cardiac output) in relation to waist-hip ratio.
- Evaluated responses to sympathoadrenal activation during mental stress.
- Investigated circulatory responses during physiological hyperinsulinemia and forearm vascular function.
Main Results:
- Central obesity correlated with elevated total peripheral resistance and lower cardiac output.
- Mental stress induced a vasoconstrictor response, not a normal pressor response, in individuals with central obesity.
- Insulin levels showed relationships with obesity degree, stress-induced vasoconstriction, and circulatory parameters; hyperinsulinemia altered stress responses and attenuated forearm vasodilation.
Conclusions:
- Central obesity is associated with a distinct hemodynamic profile (high total peripheral resistance, low cardiac output) and a vasoconstrictor response to stress.
- These hemodynamic alterations may be linked to insulin metabolism and peripheral vascular effects of insulin.